Proactive Investors - Run By Investors For Investors

Zelda enters rapidly-growing German market with product commercialisation strategy

Zelda Therapeutics Ltd (ASX:ZLD) founder and executive chairman Harry Karelis updates Proactive Investors on the cannabis company’s progress with clinical trials as well as its recent entry into the German market.
 
Zelda has entered a distribution and manufacturing strategic partnership with German medicinal cannabis group HAPA Medical.
 
As per the deal, HAPA will have first rights to distribute and/or manufacture Zelda’s clinically validated formulations into the rapidly growing German market.
 
With a population of 83 million people, Germany is estimated to have the potential to become the world’s largest single medical cannabis market.
Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use